Most U.S. states do not currently cover highly sought after weight-loss drugs from Novo Nordisk and Eli Lilly in their ...

GLP-1 drugs such as Novo Nordisk's Ozempic can cut drug and alcohol abuse by around half. Meanwhile, tech companies are ...

Despite the benefits of such medicines, like Wegovy, Saxenda and Zepbound, many people who could most benefit from them can’t ...

Ozempic maker Novo Nordisk (NVO) is asking the U.S. Food and Drug Administration (FDA) to prohibit compounding pharmacies ...

As more women speak openly about menopause and the changes it brings, some doctors say GLP-1 medications like Ozempic and ...

Food naturally boosts your body’s GLP-1 levels, explained Dr. Sun Kim, an endocrinologist at Stanford Health Care in ...

With weight loss injectables like Ozempic and Mounjaro taking the world by storm, the diet industry is seemingly being left ...

While all state Medicaid programs cover GLP-1 agonists for type 2 diabetes, it’s much less common for them to cover the drugs ...

Weight loss can be a challenging journey, especially when seeking effective and accessible solutions. The rise in popularity ...

Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.

Hims & Hers is taking a more serious approach to its latest campaign. The telehealth company, which is best known for its ...